Navigation Links
Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
Date:9/30/2013

>About Osteoarthritis
Osteoarthritis is the most common form of arthritis, affecting over 27 million people in the United States. It is a progressive disorder of the joints involving degradation of the intra-articular cartilage, joint lining, ligaments, and bone. The incidence of developing osteoarthritis of the knee or hip over a lifetime is approximately 46% and 25%, respectively. Certain risk factors in conjunction with natural wear and tear lead to the breakdown of cartilage. Osteoarthritis is caused by inflammation of the soft tissue and bony structures of the joint, which worsens over time and leads to progressive thinning of articular cartilage. Other symptoms include narrowing of the joint space, synovial membrane thickening, osteophyte formation and increased density of subchondral bone.

About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.

Forward Looking Statements
Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, and changes in business conditions a
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
2. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
3. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
4. Levine Leichtman Acquires Champion Manufacturing
5. Pro Athletes Team Up to Champion Gout Awareness
6. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
7. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
8. Ampio Pharmaceuticals to List on the NYSE MKT
9. Ampio Pharmaceuticals Provides Clinical Updates
10. Synergy Health Wins Practice Green Health Champion for Change Award
11. Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  The efficacy of ... highlighted in a recently published study 1 of ... prevention research team, including Curtis Donskey , M.D.  ... run for the same length of time from the ... (PU-UV) unit.  The results showed surprisingly low pathogen kill ...
(Date:3/31/2015)... , March 31, 2015  Frequentz Inc., a global ... a white paper to help the pharmaceutical industry understand ... Supply Chain Security Act (DSCSA). The white paper, "From ... the GS1 EPCIS Standard(s) and Implementation Plan ... the product tracing requirements that need to occur between ...
(Date:3/31/2015)... March 31, 2015  Dr. Renu Razdan of ... World Orphan Drug Congress in April to discuss the latest, ... process and orphan drugs below: India,s ... the Ministry of Health that if a new drug is ... be obtained in India with waiver ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2
(Date:3/31/2015)... Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) ... fraud resulted in $45.4 million in savings -- identified ... -- in 2014. The $45.4 million represents the highest/recovery ... Special Investigations Unit (SIU) in 1983. Since 2005, ... , “Our SIU has progressively enhanced Horizon’s analytics ...
(Date:3/31/2015)... March 31, 2015 An individual’s meniscus ... important ligaments in the leg providing stability, load bearing ... study at today’s Specialty Day meeting of the American ... MRI data to determine the potential for biologic healing ... understood about the healing of meniscus tears when a ...
(Date:3/31/2015)... March 31, 2015 Burns Engineering announces 3-Day ... for the Food & Beverage, Pharmaceutical and Biotech markets. ... are ASME-BPE compliant and are now available as part of ... running. , The S01 and S03 with 1/8” ... Ferrule process connections used in process lines 1/4” and larger. ...
(Date:3/31/2015)... The report “Coagulation/Hemostasis Analyzer Market ... Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, ... analyzes and studies the major market drivers, restraints, ... and the Rest of the world (RoW). ... to reach $3.58 billion by 2019 from $2.4 ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 ... that specializes in providing online solutions to ... today it has achieved full accreditation for ... Network Accreditation Program (HNAP) from the Electronic ... EHNAC’s HNAP accreditation runs in two-year increments ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:New Way to Evaluate Meniscus Tear Outcomes 2Health News:Burns Engineering Now Offers 3-Day Quick Ship on Sanitary RTDs and Thermocouples 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 2Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 3Health News:The Global Coagulation Analyzers Market will be Valued at $3.58 Billion in 2019 - MarketsandMarkets 4Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 2Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 3
... Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the following webcast: , , ... Friday, August 14, 2009 at 12:00 PM ET, ... Live over the Internet -- Simply log on to the web at the, ... Conference call dial-in phone numbers:, Toll-free from the US: (1 888) ...
... , , INDIANAPOLIS, Aug. 3 ... by Adventist Health System as its exclusive clearinghouse for physicians. ... portal-based clearinghouse/Revenue Cycle Management Services to improve Adventist Health System,s ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090701/RMLOGO ...
... ... Plastic Surgery Societies Reveals Surprising Answers , ... New York, NY and Arlington Heights, IL (Vocus) August 3, 2009 -- What ... person. That,s just one finding from a recent consumer survey conducted on the BeautyforLife ...
... INCLINE VILLAGE, Nev., Aug. 3 PDL BioPharma, Inc. (PDL) ... E. ("Barry") Selick, Ph.D., to the Company,s Board of Directors. , ... and his extensive knowledge of PDL,s humanization technology will allow him ... seek to maximize the value of our antibody humanization patents and ...
... HATBORO, Pa., August 3 InfoLogix, Inc. ... of enterprise mobility solutions for the healthcare and commercial industries, ... healthcare providers, the InfoLogix M24 mobile clinical assistant: a powerful ... patient information at the point-of-care. , , ...
... LITTLE FALLS, N.J., Aug. 3 CANTEL MEDICAL ... Purification subsidiary, has continued the expansion of its water purification and ... Systems Int,l, LLC. G.E.M. designs, builds, installs and services high ... The acquired business had pre-acquisition revenues of approximately $3.5 million. ...
Cached Medicine News:Health News:RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 2Health News:RealMed Named Exclusive Medical Claims Clearinghouse for Physicians by Adventist Health System 3Health News:How Do Our Attitudes About Beauty Change As We Age? 2Health News:How Do Our Attitudes About Beauty Change As We Age? 3Health News:How Do Our Attitudes About Beauty Change As We Age? 4Health News:PDL BioPharma Elects Barry Selick to Its Board of Directors 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 3Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 2Health News:Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment 3
The unique design of the TWINFIX Suture Anchors combines high resistance to pullout from our patented thread design with optimal knot tying from the DURABRAID suture....
... Micro Anchor is the smallest, strongest ... flexibility in placement into even the ... with 3-0 or 4-0 ETHIBOND EXCEL ... or cutting swaged needles. The kit ...
The Mini Anchor is an exceptionally strong, versatile anchor. This anchor comes in either a load-your-own or QUICKANCHOR format, preloaded on either 2/0 or 0 ETHIBOND EXCEL suture with swaged needles...
... Threaded Anchors (3.0mm) are ideal for soft tissue ... surgical applications. The FASTIN threaded anchor technology offers ... surgical sites. If you need a threaded anchor ... the FASTIN anchor is the anchor for you. ...
Medicine Products: